Appili Therapeutics Inc. (TSX:APLI)

Appili Therapeutics Revenue

Appili Therapeutics had revenue of 117.89K CAD in the quarter ending June 30, 2026. This brings the company's revenue in the last twelve months to 362.07K, up 260.48% year-over-year. In the fiscal year ending March 31, 2026, Appili Therapeutics had annual revenue of 244.18K with 143.10% growth.

• Revenue (ttm): 362.07K
• Revenue Growth: +260.48%
• P/S Ratio: 3.66
• Revenue / Employee: 51.72K
• Employees: 7
• Market Cap: 1.32M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	244.18K	143.74K	143.10%
Mar 31, 2025	100.44K	-726.96K	-87.86%
Mar 31, 2024	827.41K	493.23K	147.60%
Mar 31, 2023	334.18K	-1.06M	-75.97%
Mar 31, 2022	1.39M	-	-
Mar 31, 2021	-	-	-
Mar 31, 2020	199.11K	-	-
Mar 31, 2019	-	-	-
Mar 31, 2018	-	-	-

Data Source: Fiscal.ai Last updated: Aug 14, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error